<div id="readability-page-1"><div><p>Viewing insider transactions for <strong>Giant Biogene Holding Co., Ltd.'s</strong> (HKG:2367 ) over the last year, we see that insiders were net buyers. This means that a larger number of shares were purchased by insiders in relation to shares sold.</p><p> While insider transactions are not the most important thing when it comes to long-term investing,  we would consider it foolish to ignore insider transactions altogether. </p> <p>Trump has pledged to &#34;unleash&#34; American oil and gas and these 15 US stocks have developments that are poised to benefit.</p><h2> The Last 12 Months Of Insider Transactions At Giant Biogene Holding </h2> <p> In the last twelve months, the biggest single sale by an insider was when the Chief Scientific Officer, Daidi Fan, sold HK$2.3b worth of shares at a price of HK$66.65 per share.   While we don't usually like to see insider selling, it's more concerning if the sales take place at a lower price.  The silver lining is that this sell-down took place above the latest price (HK$33.84).  So it may not tell us anything about how insiders feel about the current share price.    The only individual insider seller over the last year was Daidi Fan.    Notably Daidi Fan was also the biggest buyer, having purchased HK$2.5b worth of shares.   </p> <p> Daidi Fan bought 39.23m shares over the last 12 months at an average price of HK$64.57.   You can see the insider transactions (by companies and individuals) over the last year depicted in the chart below.  If you want to know exactly who sold, for how much, and when, simply click on the graph below! </p><p><span> See our latest analysis for Giant Biogene Holding </span></p><figure><img height="872" src="https://imageproxy.pbkrs.com/https://images.simplywall.st/asset/chart/1804192419-insider-trading-volume-1-dark-2/1769475235373?x-oss-process=image/auto-orient,1/interlace,1/resize,w_1440,h_1440/quality,q_95/format,jpg" width="1642" original-src="https://imageproxy.pbkrs.com/https://images.simplywall.st/asset/chart/1804192419-insider-trading-volume-1-dark-2/1769475235373"/><figcaption>SEHK:2367 Insider Trading Volume January 27th 2026</figcaption></figure><p> Giant Biogene Holding is not the only stock insiders are buying. So take a peek at this <strong>free</strong> list of under-the-radar companies with insider buying. </p> <h2> Does Giant Biogene Holding Boast High Insider Ownership? </h2><p> Looking at the total insider shareholdings in a company can help to inform your view of whether they are well aligned with common shareholders.  I reckon it's a good sign if insiders own a significant number of shares in the company.   Giant Biogene Holding insiders own 55% of the company, currently worth about HK$20b based on the recent share price.  This kind of significant ownership by insiders does generally increase the chance that the company is run in the interest of all shareholders.  </p><h2> What Might The Insider Transactions At Giant Biogene Holding Tell Us? </h2><p> There haven't been any insider transactions in the last three months -- that doesn't mean much.    However, our analysis of transactions over the last year is heartening.   It would be great to see more insider buying, but overall it seems like Giant Biogene Holding insiders are reasonably well aligned (owning significant chunk of the company's shares) and optimistic for the future.      Of course, <strong>the future is what matters most</strong>. So if you are interested in Giant Biogene Holding, you should check out this <strong>free</strong> report on analyst forecasts for the company. </p><p> But note: <strong>Giant Biogene Holding may not be the best stock to buy</strong>. So take a peek at this <strong>free</strong> list of interesting companies with high ROE and low debt. </p><p><em>For the purposes of this article, insiders are those individuals who report their transactions to the relevant regulatory body. We currently account for open market transactions and private dispositions of direct interests only, but not derivative transactions or indirect interests.</em></p></div></div>

159837

159849

02367

516930

516500

<p>Giant Biogene Holding Co., Ltd. (HKG:2367) saw net insider buying over the past year, with Chief Scientific Officer Daidi Fan being the largest buyer, purchasing HK$2.5 billion worth of shares. Despite a significant sale of HK$2.3 billion by Fan, it occurred above the current share price of HK$33.84. Insiders own 55% of the company, valued at approximately HK$20 billion, indicating alignment with shareholders. While no transactions occurred in the last three months, the overall insider activity suggests optimism for the company's future.</p>

Giant Biogene Holding Insider Ups Holding During Year